A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HR011408 at Two Formulations in Healthy Subject

Inclusion criteria

• Male or female aged 18-55 years (both inclusive) at the time of signing informed consent.
• Body mass index 18.0-26.0kg/m2 (both inclusive).
• Body weight ≥ 50.0 kg (male),≥ 45.0 kg (female).
• Fasting serum/plasma glucose < 6.1 mmol/L.

Exclusion criteria

• Known or suspected of being allergic to any ingredient in the study drug.
• Participated in any drug or medical device-related clinical trial within 3 months before screening.
• Subjects addicted to smoking, or non-smoker who smoked within 48 hours before administration.
• Donated blood within 1 month before screening; or donated blood ≥ 400 mL or had blood loss ≥ 400 mL during trauma or major surgery within 3 months before screening.
• Subjects with incompetence or language impairment, who cannot fully understand or participate in the study.